Sylvester Comprehensive Cancer Center/ University of Miami

Miami, Florida 33146

4 studies enrolling now · 12 studies all time

What they study most

Advanced Urothelial Carcinoma, Allogeneic Hematopoietic Cell Transplant, Arteriovenous Malformation of Central Nervous System, Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), Brain Tumor, Primary, Breast Cancer, Cancer, Malignant Tumors, Cutaneous Melanoma, Desmoplastic Small Round Cell Tumor, EBV+ Lymphoproliferative Disease With Acquired (Non-congenital) Immunodeficiency (EBV+ AID LPD), EBV+ Lymphoproliferative Disease With Primary Immunodeficiency (EBV+ PID LPD), EBV+ Post-transplant Lymphoproliferative Disease (EBV+ PTLD)

Studies at this site

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) International Registry — Recruiting now
A Study of FX-909 in Patients With Advanced Solid Malignancies, Including Advanced Urothelial Carcinoma — Recruiting now
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles — Recruiting now
RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT — Recruiting now
A Study to Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated Diseases — Running, not enrolling
Study of RP1 Monotherapy and RP1 in Combination With Nivolumab (IGNYTE) — Running, not enrolling
SARC044: A Phase II Trial of Bezuclastinib in Combination With Sunitinib in Patients With GIST — Running, not enrolling
Cluster of Differentiation Antigen 19/22(CD19/22) CAR T Cells (AUTO3) for the Treatment of Diffuse Large B Cell Lymphoma — Stopped early
FOCUS: PCC + Bevacizumab + CA4P Versus PCC + Bevacizumab + Placebo for Subjects With Platinum Resistant Ovarian Cancer — Stopped early
Study of PBI-200 in Subjects With NTRK-Fusion-Positive Solid Tumors — Stopped early
Study of Cetuximab With Radiation Followed by Consolidation Chemotherapy for NSCLC — Completed
A Phase I Open Label Study of E7974 Administered on a Day 1 of 21-Day Cycle In Patients With Advanced Solid Tumors — Completed